Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Luke Evnin sold 407,574 Werewolf Therapeutics, Inc. shares (Form 4)
Traded May 8 to May 12, 2026 · Filed May 12, 2026
From May 8 to May 12, 2026, Luke Evnin (Director) sold 407,574 Werewolf Therapeutics, Inc. shares at an average US$0.69 for US$280K under a trading plan, leaving 1,171,175 shares. Filed May 12, 2026 (Form 4).
- Sold
- 407,574 shares
- Price
- US$0.69 average (US$0.64 to US$0.70)
- Value
- US$280K
- Holding after
- 1,171,175 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | Sale | 305,741 | US$0.70 | 1,273,008 | Indirect |
| May 11, 2026 | Common Stock | Sale | 33,948 | US$0.67 | 1,239,060 | Indirect |
| May 12, 2026 | Common Stock | Sale | 67,885 | US$0.64 | 1,171,175 | Indirect |
Source
Related
- Werewolf Therapeutics, Inc.
- Luke Evnin
- Werewolf Therapeutics, Inc. shareholders
- Form 4 · Luke Evnin · Jul 8, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Form 4 · Luke Evnin · Jun 10, 2026
- Form 4 · Luke Evnin · Jun 8, 2026
- Form 4 · Luke Evnin · Jun 3, 2026
- Schedule 13G · Moll Peter · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026
- Form 4 · Ra Capital Management, L.P. · Jun 22, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 22, 2026